Regarding the detection solutions, immunoassay checks to the screening of particular SCs are commercially available but need to have affirmation by LC-MS/MS and are becoming promptly out of date, as demonstrated by Franz and others [sixty]. The swift enhancement of new SCs is a limitation even for qualified mass spectrometry https://juliusy727hxm1.gynoblog.com/profile